Commonwealth Equity Services
SUPN icon

Commonwealth Equity Services’s Supernus Pharmaceuticals SUPN Stock Holding History

Commonwealth Equity Services’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$451K Buy
9,698
+1,096
+13% +$52.6K ﹤0.01% 3404
2026
Q1 		$445K Sell
8,602
-1,774
-17% -$90.3K ﹤0.01% 3311
2025
Q4 		$516K Buy
10,376
+1,910
+23% +$92.9K ﹤0.01% 3159
2025
Q3 		$405K Sell
8,466
-1,229
-13% -$49.5K ﹤0.01% 3361
2025
Q2 		$306K Buy
9,695
+109
+1% +$3.49K ﹤0.01% 3560
2025
Q1 		$314K Sell
9,586
-210
-2% -$7.44K ﹤0.01% 3454
2024
Q4 		$354K Sell
9,796
-454
-4% -$16K ﹤0.01% 3266
2024
Q3 		$320K Buy
10,250
+55
+0.5% +$1.72K ﹤0.01% 3297
2024
Q2 		$273K Buy
10,195
+350
+4% +$10.1K ﹤0.01% 3377
2024
Q1 		$336K Sell
9,845
-185
-2% -$5.51K ﹤0.01% 3171
2023
Q4 		$290K Buy
10,030
+382
+4% +$10.1K ﹤0.01% 3212
2023
Q3 		$266K Buy
9,648
+197
+2% +$6K ﹤0.01% 3135
2023
Q2 		$284K Buy
9,451
+550
+6% +$19.2K ﹤0.01% 3101
2023
Q1 		$322K Buy
8,901
+200
+2% +$7.69K ﹤0.01% 2915
2022
Q4 		$310K Sell
8,701
-1,518
-15% -$52.8K ﹤0.01% 2842
2022
Q3 		$345K Sell
10,219
-385
-4% -$12.5K ﹤0.01% 2709
2022
Q2 		$306K Buy
10,604
+181
+2% +$5.18K ﹤0.01% 2829
2022
Q1 		$336K Sell
10,423
-286
-3% -$8.77K ﹤0.01% 2877
2021
Q4 		$312K Sell
10,709
-671
-6% -$20.4K ﹤0.01% 2942
2021
Q3 		$303K Buy
11,380
+1,440
+14% +$38.7K ﹤0.01% 2919
2021
Q2 		$306K Buy
9,940
+362
+4% +$11.1K ﹤0.01% 2879
2021
Q1 		$250K Hold
9,578
– – ﹤0.01% 2942
2020
Q4 		$240K Buy
+9,578
New +$206K ﹤0.01% 2771

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Commonwealth Equity Services's SUPN Position: Q2 2026 in Review

Commonwealth Equity Services increased its Supernus Pharmaceuticals (SUPN) stake by 13% in Q2 2026, buying an estimated $52.6K and bringing the position to 9,698 shares worth $451K. The position accounts for ﹤0.01% of the portfolio, ranked #3404.

Commonwealth Equity Services first reported a position in SUPN in Q4 2020 and has held it in 23 quarters since. The position peaked at $516K in Q4 2025. 335 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Commonwealth Equity Services held 9,698 shares of Supernus Pharmaceuticals worth $451K as of Q2 2026.
  • Commonwealth Equity Services bought 1,096 Supernus Pharmaceuticals shares in Q2 2026, an estimated $52.6K.
  • Supernus Pharmaceuticals made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #3404 holding.
  • Commonwealth Equity Services first reported a position in Supernus Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
  • Commonwealth Equity Services's Supernus Pharmaceuticals position peaked at $516K in Q4 2025.
  • 335 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.